NO20033474L - Blodplate-glykoprotein 1B-alfa-fusjonspolypeptider og fremgangsmåter for deres anvendelse - Google Patents

Blodplate-glykoprotein 1B-alfa-fusjonspolypeptider og fremgangsmåter for deres anvendelse

Info

Publication number
NO20033474L
NO20033474L NO20033474A NO20033474A NO20033474L NO 20033474 L NO20033474 L NO 20033474L NO 20033474 A NO20033474 A NO 20033474A NO 20033474 A NO20033474 A NO 20033474A NO 20033474 L NO20033474 L NO 20033474L
Authority
NO
Norway
Prior art keywords
methods
fusion polypeptides
platelet glycoprotein
alpha fusion
alpha
Prior art date
Application number
NO20033474A
Other languages
English (en)
Other versions
NO20033474D0 (no
Inventor
Gray D Shaw
Ravindra Kumar
Dianne S Sako
Tom Mcdonagh
Francis X Sullivan
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of NO20033474D0 publication Critical patent/NO20033474D0/no
Publication of NO20033474L publication Critical patent/NO20033474L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20033474A 2001-02-06 2003-08-05 Blodplate-glykoprotein 1B-alfa-fusjonspolypeptider og fremgangsmåter for deres anvendelse NO20033474L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26683801P 2001-02-06 2001-02-06
PCT/US2002/003549 WO2002063003A2 (en) 2001-02-06 2002-02-06 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
NO20033474D0 NO20033474D0 (no) 2003-08-05
NO20033474L true NO20033474L (no) 2003-10-02

Family

ID=23016192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033474A NO20033474L (no) 2001-02-06 2003-08-05 Blodplate-glykoprotein 1B-alfa-fusjonspolypeptider og fremgangsmåter for deres anvendelse

Country Status (16)

Country Link
US (5) US6991796B2 (no)
EP (1) EP1360292A2 (no)
KR (1) KR20030074796A (no)
CN (1) CN100523188C (no)
AR (1) AR035779A1 (no)
AU (3) AU2002240287B2 (no)
BR (1) BR0207039A (no)
CA (1) CA2437714A1 (no)
HU (1) HUP0303167A2 (no)
IL (1) IL157264A0 (no)
MX (1) MXPA03007010A (no)
NO (1) NO20033474L (no)
NZ (1) NZ528037A (no)
PL (1) PL373052A1 (no)
WO (1) WO2002063003A2 (no)
ZA (1) ZA200306229B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
WO2004111089A2 (en) * 2003-06-11 2004-12-23 WYETH A Corporaton of the State of Delaware Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
JP2005073528A (ja) * 2003-08-28 2005-03-24 Genetics Inst Llc 生物学的系における生物学的組織への血球の接着を阻害する方法、ならびにその方法に使用するための組成物
US8039588B2 (en) * 2004-05-21 2011-10-18 The Uab Research Foundation Variable lymphocyte receptors
US20080015145A1 (en) * 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
WO2010071934A1 (en) * 2008-12-22 2010-07-01 Baker Idi Heart And Diabetes Institute Holdings Limited Modulation of platelet activation
CN102988983B (zh) * 2011-09-09 2014-06-11 苏州苏大赛尔免疫生物技术有限公司 抗人血小板膜糖蛋白Ibα嵌合抗体药物组合物
EP2794007A4 (en) * 2011-12-23 2015-11-18 Vasculogics Inc COMPOSITIONS AND METHODS FOR TREATING THROMBOSES AND EXTENDING THE LIFE OF THE STORED THROMBOCYTES
MX354719B (es) 2012-06-26 2018-03-16 Ge Healthcare As Preparacion de una composicion que comprende microburbujas de gas.
EP2919013B1 (de) * 2014-03-11 2016-11-02 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Detektion von Modulatoren der GPIb-Thrombin-Interaktion
CN107340225B (zh) * 2017-07-13 2019-07-05 徐州医科大学 一种基于流式细胞术检测血小板受体GPIba胞外段酶切的方法
TW202000692A (zh) 2018-02-20 2020-01-01 美商格里佛診斷方法股份有限公司 包含GpIbα的多肽和組合物、編碼該多肽的核酸及包含該多肽或該核酸的細胞

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5516964A (en) 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
JP3735921B2 (ja) * 1996-02-07 2006-01-18 三菱ウェルファーマ株式会社 ＧＰＩｂ・脂質複合体およびその用途
JP2002510481A (ja) * 1998-04-02 2002-04-09 ジェネンテック・インコーポレーテッド 抗体変異体及びその断片
WO1999054360A1 (fr) * 1998-04-23 1999-10-28 Ajinomoto Co., Inc. Substance possedant une activite antithrombotique et procede de detection de glycokallidine
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
US6878881B1 (en) * 2004-09-08 2005-04-12 Stephen K. Henry Modular cable protector assembly

Also Published As

Publication number Publication date
US20060093614A1 (en) 2006-05-04
KR20030074796A (ko) 2003-09-19
WO2002063003A3 (en) 2003-05-15
US20030091576A1 (en) 2003-05-15
AU2011200943A1 (en) 2011-03-24
US20030232047A1 (en) 2003-12-18
NZ528037A (en) 2006-08-31
NO20033474D0 (no) 2003-08-05
AU2006241373A1 (en) 2006-12-14
AU2002240287B2 (en) 2006-08-24
AR035779A1 (es) 2004-07-14
IL157264A0 (en) 2004-02-19
US20090148427A1 (en) 2009-06-11
US20060140935A1 (en) 2006-06-29
MXPA03007010A (es) 2004-07-08
PL373052A1 (en) 2005-08-08
US7049128B2 (en) 2006-05-23
CA2437714A1 (en) 2002-08-15
HUP0303167A2 (hu) 2003-12-29
EP1360292A2 (en) 2003-11-12
WO2002063003A2 (en) 2002-08-15
CN100523188C (zh) 2009-08-05
ZA200306229B (en) 2005-05-26
US6991796B2 (en) 2006-01-31
CN1553955A (zh) 2004-12-08
BR0207039A (pt) 2005-05-03

Similar Documents

Publication Publication Date Title
CY2014040I1 (el) Πρωτεϊνη συντηξης αλβουμινης
DK2236152T3 (da) Albuminfusionsproteiner
DK1163271T3 (da) Rekombinant IL-18 antistoffer og deres anvendelse
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
DK1578771T3 (da) Remodellering og glycokonjugering af peptider
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
IL166751A0 (en) Modified transferin-antibody fusion proteins
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DE50212857D1 (de) Fräs- und Bohrbearbeitungszentrum
NO20055731D0 (no) Cannabinoide reseptorligander og deres anvendelse
IL158751A0 (en) Recombinant fusion proteins and the trimers thereof
DE60124863D1 (de) Gegen menschliche interleukin-1-beta gerichtete rekombinante antikörper
ATE336502T1 (de) Hepatitis b kernprotein fusionsproteine
AU2003239365A8 (en) Recombinant glycosyltransferase fusion proteins
IL220272A0 (en) Platelet glycoprotein ib alpha variant fusion polypeptides
NO20034962D0 (no) Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme
NO20033474D0 (no) Blodplate-glykoprotein 1B-alfa-fusjonspolypeptider og fremgangsmåter for deres anvendelse
NO20040249L (no) Blodgruppeantigenfusjonspolypeptider og fremgangsmater for deres anvendelse
NO20015420L (no) Rekombinant blodplatekollagenreseptorglykoprotein VI og dets farmasöytiske anvendelse
NO20034432L (no) Interferon gamma polypeptidvarianter
DK1558276T3 (da) Flavivirus-fusionsinhibitorer
NO20035369D0 (no) Karakterisere polypeptider
AT500979A5 (de) Glasverbund
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
NO20034172D0 (no) Bisykliske guanidinderivater og terapeutiske anvendelser derav